Zacks Investment ResearchMon, 04 May 2026 18:15:18 GMTSMMT Q1 Loss Narrower Than Expected, Stock Down on Ivonescimab SetbackSMMT-2.35%
24/7 Wall StreetMon, 04 May 2026 15:07:33 GMTBuy These 3 Clinical-Stage Biotechs Under $30 With Solid Cash RunwaysSMMT-2.35%
BenzingaFri, 01 May 2026 15:12:01 GMTSummit Therapeutics Stock Dips After Q1 Financial ReportSMMT-2.35%
Zacks Investment ResearchThu, 16 Apr 2026 16:30:46 GMTSMMT Stock Up 24% in Three Months: Here's What You Need to KnowSMMT-2.35%
BenzingaWed, 08 Apr 2026 18:27:17 GMTSummit Therapeutics Has Scarcity Value In A Crowded Drug Race: AnalystSMMT-2.35%
Seeking AlphaWed, 11 Mar 2026 20:22:31 GMTSummit Therapeutics Inc. (SMMT) Presents at The Citizens Life Sciences Conference 2026 TranscriptSMMT-2.35%
Seeking AlphaMon, 02 Mar 2026 21:57:46 GMTSummit Therapeutics Inc. (SMMT) Presents at TD Cowen 46th Annual Health Care Conference TranscriptSMMT-2.35%
Zacks Investment ResearchTue, 24 Feb 2026 17:36:22 GMTSMMT Incurs Wider-Than-Expected Q4 Loss, Pipeline Progress in FocusSMMT-2.35%
Seeking AlphaTue, 24 Feb 2026 08:54:56 GMTSummit Therapeutics Inc. (SMMT) Q4 2025 Earnings Call TranscriptSMMT-2.35%
